Sequencing:Article Title: Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
Article Snippet: .. Bias Authors' judgement Support for judgement Random sequence generation (selection bias) All outcomes Low risk Quote: "randomisation was subsequently performed according to a code generated by the Biometry Administration Group of Global Biometry at Bayer HealthCare, Germany, by using balanced blocks of treatment group allocation and a 1:1 ratio between the two treatment group" Comment: the process adopted for randomisation appears adequate Allocation concealment (selection bias) All outcomes Low risk Quote: "the packaging site was provided with a copy of the randomization code, and investigators received sealed, patient-specific 'code-break' envelopes" Comment: the procedure adopted for allocation concealment appears to be adequate Stief 2008 (Continued) Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia (Review) Copyright © 2018 The Cochrane Collaboration. ..
Article Title: Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
Article Snippet: .. Random sequence generation (selection bias) All outcomes , Low risk , Quote: "randomisation was subsequently performed according to a code generated by the Biometry Administration Group of Global Biometry at Bayer HealthCare, Germany, by using balanced blocks of treatment group allocation and a 1:1 ratio between the two treatment group" Comment: the process adopted for randomisation appears adequate. .. Allocation concealment (selection bias) All outcomes , Low risk , Quote: "the packaging site was provided with a copy of the randomization code, and investigators received sealed, patient‐specific 'code‐break' envelopes" Comment: the procedure adopted for allocation concealment appears to be adequate.
Selection:Article Title: Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
Article Snippet: .. Bias Authors' judgement Support for judgement Random sequence generation (selection bias) All outcomes Low risk Quote: "randomisation was subsequently performed according to a code generated by the Biometry Administration Group of Global Biometry at Bayer HealthCare, Germany, by using balanced blocks of treatment group allocation and a 1:1 ratio between the two treatment group" Comment: the process adopted for randomisation appears adequate Allocation concealment (selection bias) All outcomes Low risk Quote: "the packaging site was provided with a copy of the randomization code, and investigators received sealed, patient-specific 'code-break' envelopes" Comment: the procedure adopted for allocation concealment appears to be adequate Stief 2008 (Continued) Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia (Review) Copyright © 2018 The Cochrane Collaboration. ..
Article Title: Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
Article Snippet: .. Random sequence generation (selection bias) All outcomes , Low risk , Quote: "randomisation was subsequently performed according to a code generated by the Biometry Administration Group of Global Biometry at Bayer HealthCare, Germany, by using balanced blocks of treatment group allocation and a 1:1 ratio between the two treatment group" Comment: the process adopted for randomisation appears adequate. .. Allocation concealment (selection bias) All outcomes , Low risk , Quote: "the packaging site was provided with a copy of the randomization code, and investigators received sealed, patient‐specific 'code‐break' envelopes" Comment: the procedure adopted for allocation concealment appears to be adequate.
Generated:Article Title: Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
Article Snippet: .. Bias Authors' judgement Support for judgement Random sequence generation (selection bias) All outcomes Low risk Quote: "randomisation was subsequently performed according to a code generated by the Biometry Administration Group of Global Biometry at Bayer HealthCare, Germany, by using balanced blocks of treatment group allocation and a 1:1 ratio between the two treatment group" Comment: the process adopted for randomisation appears adequate Allocation concealment (selection bias) All outcomes Low risk Quote: "the packaging site was provided with a copy of the randomization code, and investigators received sealed, patient-specific 'code-break' envelopes" Comment: the procedure adopted for allocation concealment appears to be adequate Stief 2008 (Continued) Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia (Review) Copyright © 2018 The Cochrane Collaboration. ..
Article Title: Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
Article Snippet: .. Random sequence generation (selection bias) All outcomes , Low risk , Quote: "randomisation was subsequently performed according to a code generated by the Biometry Administration Group of Global Biometry at Bayer HealthCare, Germany, by using balanced blocks of treatment group allocation and a 1:1 ratio between the two treatment group" Comment: the process adopted for randomisation appears adequate. .. Allocation concealment (selection bias) All outcomes , Low risk , Quote: "the packaging site was provided with a copy of the randomization code, and investigators received sealed, patient‐specific 'code‐break' envelopes" Comment: the procedure adopted for allocation concealment appears to be adequate.
|